|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 107, Issue 5 1137-1157, Copyright © 1994 by Company of Biologists
JOURNAL ARTICLES |
M Shah, DM Foreman and MW Ferguson
Department of Cell and Structural Biology, School of Biological Sciences, University of Manchester, UK.
Scarring is a major cause of many clinical problems. Scar tissue interferes with growth, impairs function and is aesthetically unpleasant. However, scarring does not appear to be a problem of embryonic life. Embryonic wounds heal with a lower inflammatory and angiogenic response and have a different growth factor profile compared to adult wounds. We have used neutralising antibody to transforming growth factor-beta 1,2 (TGF-beta 1,2) to alter the growth factor profile of cutaneous wounds in adult rodents and studied the effect on scar tissue formation. This paper extends our preliminary report that neutralising antibody to TGF-beta reduces cutaneous scarring in adult rodents. To be effective, the neutralising antibody to TGF-beta needs to be administered at the time of wounding or soon thereafter. The antiscarring effects of this neutralising antibody to TGF-beta were dose dependent. Exogenous addition of neutralising antibody to TGF-beta to incisional wounds reduced the inflammatory and angiogenic responses and reduced the extracellular matrix deposition in the early stages of wound healing without reducing the tensile strength of the wounds. Importantly, the architecture of the neodermis of wounds treated with neutralising antibody to TGF-beta resembled more closely that of normal dermis compared to the unmanipulated control wounds, which healed with an abnormal neodermal architecture resulting in obvious scarring. This study suggests a novel therapeutic approach to reducing scarring in post-natal life.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  A. How, J. L. L. Chua, A. Charlton, R. Su, M. Lim, R. S. Kumar, J. G. Crowston, and T. T. Wong Combined Treatment with Bevacizumab and 5-Fluorouracil Attenuates the Postoperative Scarring Response after Experimental Glaucoma Filtration Surgery Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 928 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Durani, N. Occleston, S. O'Kane, and M. W. J. Ferguson Avotermin: A Novel Antiscarring Agent International Journal of Lower Extremity Wounds, September 1, 2008; 7(3): 160 - 168. [Abstract] [PDF]
|
|
|
|
 |
|
 A. D Metcalfe and M. W.J Ferguson Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration J R Soc Interface, June 22, 2007; 4(14): 413 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leask TGF{beta}, cardiac fibroblasts, and the fibrotic response Cardiovasc Res, May 1, 2007; 74(2): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mori, K. T. Power, C. M. Wang, P. Martin, and D. L. Becker Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration J. Cell Sci., December 15, 2006; 119(24): 5193 - 5203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Bates, E. Morrow, A. Y. Zhang, H. Pham, M. T. Longaker, and J. Chang Mannose-6-Phosphate, an Inhibitor of Transforming Growth Factor-beta, Improves Range of Motion After Flexor Tendon Repair J. Bone Joint Surg. Am., November 1, 2006; 88(11): 2465 - 2472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L Jones, C. Stoikos, J. K Findlay, and L. A Salamonsen TGF-{beta} superfamily expression and actions in the endometrium and placenta. Reproduction, August 1, 2006; 132(2): 217 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Greenberg, A. M. Bernstein, M. Benezra, I. H. Gelman, L. Taliana, and S. K. Masur FAK-dependent regulation of myofibroblast differentiation FASEB J, May 1, 2006; 20(7): 1006 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V Yannas Similarities and differences between induced organ regeneration in adults and early foetal regeneration J R Soc Interface, December 22, 2005; 2(5): 403 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kopp, E. Preis, H. Said, B. Hafemann, L. Wickert, A. M. Gressner, N. Pallua, and S. Dooley|| Abrogation of Transforming Growth Factor-{beta} Signaling by SMAD7 Inhibits Collagen Gel Contraction of Human Dermal Fibroblasts J. Biol. Chem., June 3, 2005; 280(22): 21570 - 21576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chockalingam, M. J. Paape, and D. D. Bannerman Increased Milk Levels of Transforming Growth Factor-{alpha}, {beta}1, and {beta}2 During Escherichia coli-Induced Mastitis J Dairy Sci, June 1, 2005; 88(6): 1986 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guo, S. E. Moss, R. A. Alexander, R. R. Ali, F. W. Fitzke, and M. F. Cordeiro Retinal Ganglion Cell Apoptosis in Glaucoma Is Related to Intraocular Pressure and IOP-Induced Effects on Extracellular Matrix Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grisanti, P. Szurman, M. Warga, R. Kaczmarek, F. Ziemssen, O. Tatar, and K. U. Bartz-Schmidt Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Prime, M. Pring, M. Davies, and I.C. Paterson TGF-{beta} SIGNAL TRANSDUCTION IN ORO-FACIAL HEALTH AND NON-MALIGNANT DISEASE (PART I) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 324 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Wilgus, V. K. Bergdall, K. L. Tober, K. J. Hill, S. Mitra, N. A. Flavahan, and T. M. Oberyszyn The Impact of Cyclooxygenase-2 Mediated Inflammation on Scarless Fetal Wound Healing Am. J. Pathol., September 1, 2004; 165(3): 753 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Ettema, P. C. Amadio, C. Zhao, L. E. Wold, and K.-N. An A Histological and Immunohistochemical Study of the Subsynovial Connective Tissue in Idiopathic Carpal Tunnel Syndrome J. Bone Joint Surg. Am., July 1, 2004; 86(7): 1458 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Martin and S. M. Parkhurst Parallels between tissue repair and embryo morphogenesis Development, July 1, 2004; 131(13): 3021 - 3034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. LEASK and D. J. ABRAHAM TGF-{beta} signaling and the fibrotic response FASEB J, May 1, 2004; 18(7): 816 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Sorrell and A. I. Caplan Fibroblast heterogeneity: more than skin deep J. Cell Sci., March 1, 2004; 117(5): 667 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sukotjo, A. Lin, K. Song, T. Ogawa, B. Wu, and I. Nishimura Oral Fibroblast Expression of wound-inducible transcript 3.0 (wit3.0) Accelerates the Collagen Gel Contraction in Vitro J. Biol. Chem., December 19, 2003; 278(51): 51527 - 51534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Soo, S. R. Beanes, F.-Y. Hu, X. Zhang, C. Dang, G. Chang, Y. Wang, I. Nishimura, E. Freymiller, M. T. Longaker, et al. Ontogenetic Transition in Fetal Wound Transforming Growth Factor-{beta} Regulation Correlates with Collagen Organization Am. J. Pathol., December 1, 2003; 163(6): 2459 - 2476. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Mead, T. T. L. Wong, M. F. Cordeiro, I. K. Anderson, and P. T. Khaw Evaluation of Anti-TGF-{beta}2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3394 - 3401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. WERNER and R. GROSE Regulation of Wound Healing by Growth Factors and Cytokines Physiol Rev, July 1, 2003; 83(3): 835 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. McKaig, D. McWilliams, S. A. Watson, and Y. R. Mahida Expression and Regulation of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinases by Intestinal Myofibroblasts in Inflammatory Bowel Disease Am. J. Pathol., April 1, 2003; 162(4): 1355 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chamberlain, J. Gunn, S. E. Francis, C. M. Holt, N. D. Arnold, D. C. Cumberland, M. W.J. Ferguson, and D. C. Crossman TGF{beta} is active, and correlates with activators of TGF{beta}, following porcine coronary angioplasty Cardiovasc Res, April 1, 2001; 50(1): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chen, B. Michelini–Norris, S. Stevens, J. Rowsey, X.-o. Ren, M. Goldstein, and G. Schultz Measurement of mRNAs for TGF{beta} and Extracellular Matrix Proteins in Corneas of Rats after PRK Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4108 - 4116. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Abraham, X. Shiwen, C. M. Black, S. Sa, Y. Xu, and A. Leask Tumor Necrosis Factor alpha Suppresses the Induction of Connective Tissue Growth Factor by Transforming Growth Factor-beta in Normal and Scleroderma Fibroblasts J. Biol. Chem., May 12, 2000; 275(20): 15220 - 15225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ravanti, L. Hakkinen, H. Larjava, U. Saarialho-Kere, M. Foschi, J. Han, and V.-M. Kahari Transforming Growth Factor-beta Induces Collagenase-3 Expression by Human Gingival Fibroblasts via p38 Mitogen-activated Protein Kinase J. Biol. Chem., December 24, 1999; 274(52): 37292 - 37300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, J. A. Gay, and P. T. Khaw Human Anti-Transforming Growth Factor-{beta}2 Antibody: A New Glaucoma Anti-Scarring Agent Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, M. B. Reichel, J. A. Gay, F. D’Esposita, R. A. Alexander, and P. T. Khaw Transforming Growth Factor-{beta}1, -{beta}2, and -{beta}3 In Vivo: Effects on Normal and Mitomycin C-Modulated Conjunctival Scarring Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1975 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. McKaig, S. S. Makh, C. J. Hawkey, D. K. Podolsky, and Y. R. Mahida Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta 3 Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1087 - G1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Shah, D. Revis, S. Herrick, R. Baillie, S. Thorgeirson, M. Ferguson, and A. Roberts Role of Elevated Plasma Transforming Growth Factor-ß1 Levels in Wound Healing Am. J. Pathol., April 1, 1999; 154(4): 1115 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yang, C. X. Qiu, A. Ludlow, M. W. J. Ferguson, and G. Brunner Active Transforming Growth Factor-ß in Wound Repair : Determination Using a New Assay Am. J. Pathol., January 1, 1999; 154(1): 105 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B Reichel, M F. Cordeiro, R. A Alexander, I. A Cree, S. S Bhattacharya, and P. T Khaw New model of conjunctival scarring in the mouse eye Br J Ophthalmol, September 1, 1998; 82(9): 1072 - 1077. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Wu, A. Siddiqui, D. E. Morris, D. A. Cox, S. I. Roth, and T. A. Mustoe Transforming Growth Factor {beta}3 (TGF{beta}3) Accelerates Wound Healing Without Alteration of Scar Prominence: Histologic and Competitive Reverse-Transcription-Polymerase Chain Reaction Studies Arch Surg, July 1, 1997; 132(7): 753 - 760. [Abstract] [PDF]
|
|
|
|
|
|
S. Frank, M. Madlener, and S. Werner Transforming Growth Factors beta1, beta2, and beta3 and Their Receptors Are Differentially Regulated during Normal and Impaired Wound Healing J. Biol. Chem., April 26, 1996; 271(17): 10188 - 10193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Talts, A Weller, R Timpl, M Ekblom, and P Ekblom Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma J. Cell Sci., January 6, 1995; 108(6): 2153 - 2162. [Abstract] [PDF]
|
|
|
|
|
|
M Shah, D. Foreman, and M. Ferguson Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring J. Cell Sci., January 3, 1995; 108(3): 985 - 1002. [Abstract] [PDF]
|
|
|
|
 |
|
 B. C. McKaig, K. Hughes, P. J. Tighe, and Y. R. Mahida Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts Am J Physiol Cell Physiol, January 1, 2002; 282(1): C172 - C182. [Abstract] [Full Text] [PDF]
|
|
